Busque Philippe bought CTKB
March 20, 2024 · Form 4 insider transaction
Busque Philippe bought 5,464 shares of Cytek Biosciences, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,464
Price
N/A
Total value
N/A
InsiderBusque Philippe
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 20, 2024
Filing dateMarch 21, 2024
Shares owned after5,464
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.